please separate multiple tags with commas.
6  Messages
ProSiebenSat.1 confirms full-year outlook for 2022
Results in the first quarter of 2022 in line with the Group’s expectations: Synergistic business model demonstrates resilience despite Russia-Ukraine war, ongoing pandemic, and strains on consumer sentiment. Group revenues grow by 2% (organically1: +3%) to EUR 954 million; the significant growth more
  • Date: 12.05.2022
  • Keywords:  Quarterly Results, Financial Figures Q1 2022, Outlook 2022
ProSiebenSat.1 Annual General Meeting elects Supervisory Board members – Dr. Andreas Wiele new Chairman of the Supervisory Board
Meeting follows recommendation to re-elect Prof. Dr. Rolf Nonnenmacher and elect Bert Habets to the Supervisory Board Annual General Meeting agrees to proposed dividend of EUR 0.80 per dividend-bearing share Shareholders approve all other proposed resolutions and grant discharge to the Executive more
  • Date: 05.05.2022
  • Keywords:  Annual General Meeting
ProSiebenSat.1 invites to the virtual Annual General Meeting of shareholders on May 5, 2022
The Company publishes the invitation to the AGM for May 5, 2022 Proposed distribution of a dividend of 0.80 EUR per no-par value share entitled to dividend; Increase of 63% compared to the previous year Dr. Andreas Wiele to become Chairman of the Supervisory Board and succeed Dr. Werner Brandt, who more
  • Date: 28.03.2022
ProSiebenSat.1 closes 2021 with revenue growth of 11%; adjusted EBITDA increases by a considerable 19%
2021 results  New record revenues with growth of 11% to EUR 4,494 million Full-year advertising revenues again above pre-crisis 2019 level despite ongoing pandemic and weak Q1 2021 Significant increase in adjusted EBITDA of 19% to EUR 840 million and in adjusted net income of 64% to EUR 362 more
  • Date: 03.03.2022
Disclosure of an inside information pursuant to article 17 MAR of the regulation (EU) no. 596/2014: Dr. Andreas Wiele to become Chairman of the Supervisory Board
Chairman of the Supervisory Board Dr. Werner Brandt will not stand for re-election after two election periods at the Annual General Meeting to be held in May 2022 Dr. Andreas Wiele already appointed by Court as successor to Adam Cahan effective February 13, 2022 Munich, December 6, 2021. The more
  • Date: 06.12.2021
  • Keywords:  Ad-Hoc-Disclosure, Supervisory Board
Dr. Andreas Wiele to become Chairman of the Supervisory Board
Chairman of the Supervisory Board Dr. Werner Brandt will not stand for re-election after two election periods at the Annual General Meeting to be held in May 2022  Dr. Andreas Wiele already appointed by Court as successor to Adam Cahan effective February 13, 2022 Bert Habets to be proposed for more
  • Date: 06.12.2021
  • Keywords:  Supervisory Board, Management Changes